Restoring Natural Killer Cell Immunity Against Multiple Myeloma in the Era of New Drugs

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2017.01444
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Entering a New Era of Harnessing Natural Killer Cell Responses in HIV Infection

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Preclinical Evaluation of Invariant Natural Killer T-Cells in the 5T33 Multiple Myeloma Model

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Review New Drugs in Multiple Myeloma – Role of Carfilzomib and Pomalidomide

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2014English

Ultrasound-Guided Radiofrequency Ablation Enhances Natural Killer-Mediated Antitumor Immunity Against Liver Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Novel Drugs for the Treatment of Multiple Myeloma

Haematologica
Hematology
2010English

Natural Killer(NK) Cell Activity in Patients With Various Malignancy Against a Variety of Target Cell Lines: Re-Evaluation of Clinical Significance of Natural Killer Cell Activity.

Japanese Journal of Medicine
1989English

The Requirement for DNAM-1, NKG2D, and NKp46 in the Natural Killer Cell-Mediated Killing of Myeloma Cells

Cancer Research
Cancer ResearchOncology
2007English

From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies

Frontiers in Immunology
AllergyImmunology
2019English

Natural Killer T Cell Activation Protects Mice Against Experimental Autoimmune Encephalomyelitis

Journal of Experimental Medicine
MedicineAllergyImmunology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy